New hope for Tough-to-Treat myeloma: phase 3 trial launches
NCT ID NCT07569757
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called TQB2934 in 260 people whose multiple myeloma has returned or stopped responding to treatment. Participants are randomly assigned to receive either TQB2934 or one of several standard treatments chosen by their doctor. The main goal is to see if TQB2934 can delay the cancer from getting worse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Chengde Medical University
Chengde, Hebei, 067000, China
-
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, 524023, China
-
Beijing Chao-Yang Hospital,Capital Medical University
Beijing, Beijing Municipality, 100020, China
-
Beijing Jishuitan Hospital,Capital Medical University
Beijing, Beijing Municipality, 100020, China
-
Binzhou Medical University Hospital
Binzhou, Shandong, 256600, China
-
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute,Shandong Cancer Hospital)
Jinan, Shandong, 250117, China
-
Cangzhou People'S Hospital
Cangzhou, Hebei, 061000, China
-
Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Central Hospital)
Lanzhou, Gansu, 730000, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
Henan Provincial People'S Hospital
Zhengzhou, Henan, 450000, China
-
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, 46000, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, 210029, China
-
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, 330038, China
-
Jining No.1 People'S Hospital
Jining, Shandong, 272111, China
-
Lanzhou University Second Hospital
Lanzhou, Gansu, 730030, China
-
Luoyang Central Hospital
Luoyang, Henan, 471000, China
-
Ningbo No.2 Hospitai
Ningbo, Zhejiang, 315016, China
-
People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang, 830000, China
-
Qingdao Municipal Hospital
Qingdao, Shandong, 266011, China
-
Shandong Provincial Hospital Affiliated to Shandong First Medical University（Shandong Provincial Hospital）
Jinan, Shandong, 250021, China
-
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, 30000, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110000, China
-
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
-
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, 510062, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550001, China
-
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646000, China
-
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221004, China
-
The First Affiliated Hospital Of Zhengzhou University
Zhengzhou, Henan, 451191, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230022, China
-
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, 233004, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530000, China
-
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650000, China
-
The First Affiliated Hospital of Ningbo Universty
Ningbo, Zhejiang, 315000, China
-
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi'an, Shaanxi, 710048, China
-
The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310000, China
-
The Second Affiliated Hospital Of Xi'an Jiaotong University
Xi'an, Shaanxi, 710004, China
-
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150086, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
-
The Second Hospital of Hebeimedical University
Shijiazhuang, Hebei, 050000, China
-
The Southwest Hospital of Amu
Chongqing, Chongqing Municipality, 400038, China
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
-
Tianjin Union Medical Center
Tianjin, Tianjin Municipality, 300121, China
-
ZhongShan Hospital Fudan University
Shanghai, Shanghai Municipality, 200032, China
-
Zhongda Hospital Southeast University
Nanjing, Jiangsu, 210009, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510280, China
-
Zhuzhou Central Hospital
Zhuzhou, Hunan, 412007, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact